Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: Coenzyme Q-10: Topical Application Gel Form
Intervention2: Injectable PRF: PRF In Injectable form
Control Intervention1: Topical Corticosteroid: Triamcinolone Acetonide 0.1%
Sponsors
SGT University
Eligibility
Inclusion criteria
Inclusion criteria: Patients who agree for the biopsy Patients satisfying the clinical and histopathological criteria as per the modified WHO
Exclusion criteria
Exclusion criteria: 1. Patients taking already systemic drugs such as steroids or other immunosuppressive therapies for at atleast 8 weeks prior to the study. 2. Patients treated with any topical medications for atleast four weeks prior to the study . 3. Pregnant and lactating mother. 4. Presence of candidiasis before therapy. 5. Patient presenting with contraindicates for corticosteroids use, immunodeficiency or severe haematological alterations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Evaluate Visual Analog Scale, VAS SCORE Improvement in Patients. To Evaluate the Reduction in Size of The LesionTimepoint: baseline, 4 weeks & 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Puneeta Vohra
SGT University
Outcome results
None listed